Snapshot from Aug 27, 2026 at 07:00 UTC. For live data and tracking: View Live
Events / Regulatory / Park Ha Securities Class Action
Regulatory class action

Park Ha Securities Class Action

Analysis based on 6 articles · First reported Aug 23, 2026 · Last updated Aug 27, 2026

Sentiment
-30
Attention
2
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The class action lawsuit against Park Ha Biological Technology Company could negatively impact its stock price and investor confidence, as allegations of fraudulent stock promotion and IPO manipulation may lead to regulatory scrutiny and potential financial penalties. The lawsuit also highlights risks for investors in small-cap biotech IPOs with low public floats, potentially affecting market sentiment toward similar offerings.

Biotechnology Legal Services
Event Summary

Rosen Law Firm, a global investor rights law firm, has filed a class action lawsuit against Park Ha Biological Technology Company Co., Ltd. (NASDAQ: PHH, BYAH) on behalf of purchasers of Park Ha securities between December 27, 2024 and July 8, 2025. The lawsuit alleges that Park Ha made materially false and misleading statements and failed to disclose material adverse facts about its business, operations, and the true nature of its securities trading activity. Specifically, the complaint alleges that Park Ha was the subject of a fraudulent stock promotion scheme involving social media-based misinformation and impersonated financial professionals, that its public statements and risk disclosures omitted mention of false rumors and artificial trading activity, and that its IPO was intentionally structured with an extremely low public float to enable the manipulation scheme. Rosen Law Firm reminds investors of the September 28, 2026 lead plaintiff deadline. The class action has already been filed, and investors who purchased Park Ha securities during the Class Period may be entitled to compensation without out-of-pocket fees through a contingency fee arrangement.

Key Actions
90 Rosen Law Firm filed class action Park Ha Biological Technology Company
Entities Involved
stock
Park Ha Biological Technology Company
Park Ha Biological Technology Company is the defendant in the class action, facing allegations of securities fraud and stock manipulation, which could lead to significant financial liability and reputational damage.
Importance 100.0 Sentiment -70.0
priv
Rosen Law Firm
Rosen Law Firm is the plaintiff's law firm leading the class action, which could enhance its reputation and generate legal fees if successful.
Importance 80.0 Sentiment 20.0
per
Lawrence Rosen
Lawrence Rosen is a founding partner of Rosen Law Firm and is involved in the case, potentially benefiting from the firm's success.
Importance 30.0 Sentiment 10.0
per
Philip Kim
Philip Kim is an attorney at Rosen Law Firm handling the case, potentially benefiting from the firm's success.
Importance 30.0 Sentiment 10.0
Relationships
Rosen Law Firm related ↔ Lawrence Rosen
Rosen Law Firm related ↔ Philip Kim
Lawrence Rosen managing partner ↔ Philip Kim Lawrence Rosen is the founder and managing partner of Rosen Law Firm, where Philip Kim is a partner, and they actively c
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.